UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis

International journal of molecular sciences, 2022-01, Vol.23 (2), p.929

2022

Volltextzugriff (PDF)

On the emerging role of GALNT2 on intermediate metabolism and adipogenesis

Acta diabetologica, 2022-09, Vol.59 (9), p.1255-1256

2022

Volltextzugriff (PDF)

GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Acta diabetologica, 2024, Vol.61 (8), p.1007-1013

2024

Volltextzugriff (PDF)

Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Acta diabetologica, 2024, Vol.61 (8), p.1015-1015

2024

Volltextzugriff (PDF)

GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling

International Journal of Obesity, 2019-12, Vol.43 (12), p.2448-2457

2019

Volltextzugriff (PDF)

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus

American journal of human genetics, 2015-07, Vol.97 (1), p.177-185

2015

Volltextzugriff (PDF)

Morphological and molecular characterization of GALNT2-mediated adipogenesis

International Journal of Obesity, 2021-06, Vol.45 (6), p.1362-1366

2021

Volltextzugriff (PDF)

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Acta diabetologica, 2023-01, Vol.60 (1), p.131-135

2023

Volltextzugriff (PDF)

Correction to: MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Acta diabetologica, 2023-03, Vol.60 (3), p.459-459

2023

Volltextzugriff (PDF)

Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes

Genes, 2022-01, Vol.13 (1), p.117

2022

Volltextzugriff (PDF)

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

PloS one, 2013-06, Vol.8 (6), p.e64729-e64729

2013

Volltextzugriff (PDF)

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia

PloS one, 2013-07, Vol.8 (7), p.e70159-e70159

2013

Volltextzugriff (PDF)

ENPP1 affects insulin action and secretion: evidences from in vitro studies

PloS one, 2011-05, Vol.6 (5), p.e19462

2011

Volltextzugriff (PDF)

Association of a homozygous GCK missense mutation with mild diabetes

Molecular genetics & genomic medicine, 2019-07, Vol.7 (7), p.e00728-n/a

2019

Volltextzugriff (PDF)

Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action

Biochimica et biophysica acta. Molecular cell research, 2013-06, Vol.1833 (6), p.1388-1395

2013

Volltextzugriff (PDF)

The Need to Increase Clinical Skills and Change the Genetic Testing Strategy for Monogenic Diabetes

Diabetes (New York, N.Y.), 2022-03, Vol.71 (3), p.379-380

2022

Volltextzugriff (PDF)

Common Haplotypes at the Adiponectin Receptor 1 (ADIPOR1) Locus Are Associated With Increased Risk of Coronary Artery Disease in Type 2 Diabetes

Diabetes (New York, N.Y.), 2006-10, Vol.55 (10), p.2763-2770

2006

Volltextzugriff (PDF)

Early-Onset Diabetes in an Infant with a Novel Frameshift Mutation in LRBA

International journal of environmental research and public health, 2022-09, Vol.19 (17), p.11031

2022

Volltextzugriff (PDF)

GALNT2 mRNA levels are associated with serum triglycerides in humans

Endocrine, 2016-07, Vol.53 (1), p.331-334

2016

Volltextzugriff (PDF)

RNASEH1 Mutations Impair mtDNA Replication and Cause Adult-Onset Mitochondrial Encephalomyopathy

American journal of human genetics, 2015-07, Vol.97 (1), p.186-193

2015

Volltextzugriff (PDF)

Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation

Nutrition, metabolism, and cardiovascular diseases, 2007-03, Vol.17 (3), p.181-187

2007

Volltextzugriff (PDF)

Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action: GALNT2: a novel modulator of insulin signaling

Biochimica et biophysica acta, 2013-06, Vol.1833 (6), p.1388

2013

Volltextzugriff (PDF)

Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia

The journal of clinical endocrinology and metabolism, 2022-03, Vol.107 (3), p.668-684

2022

Volltextzugriff (PDF)

Leveraging Genetics to Address the Role of GALNT2 on Atherogenic Dyslipidemia

Advanced biology, 2023-09, Vol.7 (9), p.e2200319-e2200319

2023

Volltextzugriff (PDF)

Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals

Scientific reports, 2017-03, Vol.7 (1), p.44337-44337, Article 44337

2017

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Englisch
(72)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis

On the emerging role of GALNT2 on intermediate metabolism and adipogenesis

GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus

Morphological and molecular characterization of GALNT2-mediated adipogenesis

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Correction to: MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia

ENPP1 affects insulin action and secretion: evidences from in vitro studies

Association of a homozygous GCK missense mutation with mild diabetes

Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action

The Need to Increase Clinical Skills and Change the Genetic Testing Strategy for Monogenic Diabetes

Common Haplotypes at the Adiponectin Receptor 1 (ADIPOR1) Locus Are Associated With Increased Risk of Coronary Artery Disease in Type 2 Diabetes

Early-Onset Diabetes in an Infant with a Novel Frameshift Mutation in LRBA

GALNT2 mRNA levels are associated with serum triglycerides in humans

RNASEH1 Mutations Impair mtDNA Replication and Cause Adult-Onset Mitochondrial Encephalomyopathy

Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation

Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action: GALNT2: a novel modulator of insulin signaling

Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia

Leveraging Genetics to Address the Role of GALNT2 on Atherogenic Dyslipidemia

Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals

Suchergebnisse filtern